Challenges and Opportunities for Quantitative Clinical Pharmacology in Cancer Immunotherapy: Something Old, Something New, Something Borrowed, and Something Blue-Reference-Cited by-同舟云学术

Challenges and Opportunities for Quantitative Clinical Pharmacology in Cancer Immunotherapy: Something Old, Something New, Something Borrowed, and Something Blue

Published:2015-09 Issue:9 Volume:4 Page:495-497
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Stroh M¹,Carlile DJ²,Li C-C¹,Wagg J³,Ribba B³,Ramanujan S⁴,Jin J¹,Xu J¹,Charoin J-E³,Xhu Z-X⁵,Morcos PN⁴,Davis JD¹,Phipps A²

Affiliation:

1. Department of Clinical Pharmacology; Genentech; South San Francisco California USA

2. Department of Clinical Pharmacology; F. Hoffmann-La Roche, Roche Innovation Center; Welwyn UK

3. Roche Innovation Center Basel; Switzerland

4. Department of Preclinical and Translational PKPD; Genentech; South San Francisco CA USA

5. Roche Innovation Center New York; New York USA

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/psp4.12014/fullpdf

Reference10 articles.

1. Cancer immunotherapy-revisited;Lesterhuis;Nat. Rev. Drug Discov,2011

2. Nivolumab plus ipilimumab in advanced melanoma;Wolchok;N. Engl. J. Med,2013

3. Oncology meets immunology: the cancer-immunity cycle;Chen;Immunity,2013

4. Patient responses to ipilimumab, a novel immunopotentiator for metastatic melanoma: how different are these from conventional treatment responses?;Pennock;Am. J Clin Oncol,2012

5. Mathematical model approach to describe tumour response in mice after vaccine administration and its applicability to immune-stimulatory cytokine-based strategies;Parra-Guillen;AAPS J,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of a patient‐centered reverse translational systems‐based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors;Clinical and Translational Science;2022-03-05

2. Pan‐cancer population pharmacokinetics and exposure‐safety and ‐efficacy analyses of atezolizumab in patients with high tumor mutational burden;Pharmacology Research & Perspectives;2020-11-25

3. Transforming preclinical assessment to meet clinical relevance with advanced models;Current Opinion in Toxicology;2020-10

4. Quantitative Systems Pharmacology: An Exemplar Model‐Building Workflow With Applications in Cardiovascular, Metabolic, and Oncology Drug Development;CPT: Pharmacometrics & Systems Pharmacology;2019-06

5. Recruiting the Immune System Against Disease: Lessons for Clinical and Systems Pharmacology;CPT: Pharmacometrics & Systems Pharmacology;2019-05-24